Header Logo

Connection

KEVIN GAREY to Oxadiazoles

Back to Details
This is a "connection" page, showing publications KEVIN GAREY has written about Oxadiazoles.
KEVIN GAREY
Connection Strength
0.058
Oxadiazoles
  1. A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response. Clin Infect Dis. 2024 06 14; 78(6):1462-1472.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.